Saphnelo Injection, Solution
Product Images NDC 0310-3080

36 FDA label images from Astrazeneca Pharmaceuticals Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 36 technical images submitted to the FDA as part of the official labeling for Saphnelo (NDC 0310-3080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure_1 (Image 01)

Figure_1 (Image 01)
A line graph comparing the proportion of BICLA responders over time (in weeks) between anifrolumab-fnia 300 mg (N=180) and placebo (N=182). The y-axis shows the proportion of responders with error bars representing standard error. The x-axis shows time from 0 to 52 weeks. The anifrolumab-fnia group consistently shows a higher proportion of responders than placebo throughout the study period.*
FDA Label Image

Pre-filled-syringe-parts-before-use (Pre Filled Syringe Parts Before Use)

Pre-filled-syringe-parts-before-use (Pre Filled Syringe Parts Before Use)
Illustration of a pre-use subcutaneous injection syringe for SAPHNELO (Anifrolumab-fnia), labeling key parts including the needle cover, needle, syringe body with an expiration date label and viewing window, finger flange, plunger with needle guard activation clips, and plunger head.*
FDA Label Image

Pre-filled-syringe-parts-after-use (Pre Filled Syringe Parts After Use)

Pre-filled-syringe-parts-after-use (Pre Filled Syringe Parts After Use)
Illustration showing parts of a subcutaneous injection device after use, including the needle guard covering the needle, the plunger, and the covered needle. The diagram is labeled with key components to demonstrate safe needle protection post-injection.*
FDA Label Image

Prefilled_syringe_supplies (Prefilled Syringe Supplies)

Prefilled_syringe_supplies (Prefilled Syringe Supplies)
Illustration showing the contents of the SAPHNELO injection kit, including one prefilled syringe from the refrigerator. It indicates that an alcohol wipe, a cotton ball or gauze, a small bandage, and a sharps disposal container are not included in the kit.*
FDA Label Image

60min-step2-image (60min Step2 Image)

60min-step2-image (60min Step2 Image)
An illustration of a stopwatch showing "60 min" in the center, likely indicating a time duration or wait period related to the product SAPHNELO (anifrolumab-fnia) injection.*
FDA Label Image

Pre-filled-syringe-step-3 (Pre Filled Syringe Step 3)

Pre-filled-syringe-step-3 (Pre Filled Syringe Step 3)
An instructional illustration showing a hand holding a prefilled syringe for SAPHNELO (anifrolumab-fnia) injection, solution, with a label indicating the location of the expiration date on the syringe barrel. The image highlights proper handling of the subcutaneous injection device.*
FDA Label Image

Pre-filled-syringe-step-4 (Pre Filled Syringe Step 4)

Pre-filled-syringe-step-4 (Pre Filled Syringe Step 4)
An anatomical illustration showing recommended injection sites for SAPHNELO injection, solution in a human figure. Shaded areas on the upper arms indicate injections by a caregiver only, while shaded areas on the abdomen and front thighs indicate sites for self-injection or injection by a caregiver.*
FDA Label Image

Pre-filled-syringe-step-5-hand-wash (Pre Filled Syringe Step 5 Hand Wash)

Pre-filled-syringe-step-5-hand-wash (Pre Filled Syringe Step 5 Hand Wash)
An instructional illustration showing a person washing hands under running water from a faucet, with water splashing onto the hands and fingers. This image likely demonstrates hand hygiene or preparation steps related to injection or medication administration.*
FDA Label Image

Pre-filled-syringe-step-5-alcohol-wipe (Pre Filled Syringe Step 5 Alcohol Wipe)

Pre-filled-syringe-step-5-alcohol-wipe (Pre Filled Syringe Step 5 Alcohol Wipe)
An instructional illustration depicting a hand peeling off a protective adhesive patch or tape from a surface, likely related to preparing the skin for subcutaneous injection.*
FDA Label Image

Pre-filled-syringe-step-6 (Pre Filled Syringe Step 6)

Pre-filled-syringe-step-6 (Pre Filled Syringe Step 6)
Instructional illustration showing hands preparing a syringe for injection by removing a protective cap from the needle before use. The image depicts proper handling steps for an injection, specifically related to the subcutaneous administration of the drug.*
FDA Label Image

Pre-filled-syringe-step-7-holding-syringe (Pre Filled Syringe Step 7 Holding Syringe)

Pre-filled-syringe-step-7-holding-syringe (Pre Filled Syringe Step 7 Holding Syringe)
An instructional illustration demonstrating a hand holding a syringe preparing for a subcutaneous injection on the skin of the opposite hand. The image visually guides the proper technique for administering a subcutaneous injection.*
FDA Label Image

Pre-filled-syringe-step-7-image-a (Pre Filled Syringe Step 7 Image A)

Pre-filled-syringe-step-7-image-a (Pre Filled Syringe Step 7 Image A)
Illustration showing a hand holding a syringe at a 45-degree angle, injecting into the skin of a forearm. The image likely demonstrates the correct subcutaneous injection technique.*
FDA Label Image

Pre-filled-syringe-step-7-image-b (Pre Filled Syringe Step 7 Image B)

Pre-filled-syringe-step-7-image-b (Pre Filled Syringe Step 7 Image B)
An instructional illustration showing how to administer a subcutaneous injection using a prefilled syringe or autoinjector. It depicts a hand holding the device against the skin of another person's finger, indicating the injection process.*
FDA Label Image

Pre-filled-syringe-step-7-image-c (Pre Filled Syringe Step 7 Image C)

Pre-filled-syringe-step-7-image-c (Pre Filled Syringe Step 7 Image C)
An instructional illustration showing hands preparing a prefilled injection device by lifting a cap off the syringe. This is part of the administration process for SAPHNELO (Anifrolumab-fnia) subcutaneous injection.*
FDA Label Image

Pre-filled-syringe-step-8 (Pre Filled Syringe Step 8)

Pre-filled-syringe-step-8 (Pre Filled Syringe Step 8)
An instructional illustration showing a hand holding a small piece of cloth or gauze, likely demonstrating how to clean or prepare an injection site for subcutaneous administration of SAPHNELO (Anifrolumab-fnia) injection solution.*
FDA Label Image

Pre-filled-syringe-step-9 (Pre Filled Syringe Step 9)

Pre-filled-syringe-step-9 (Pre Filled Syringe Step 9)
An instructional illustration showing the proper disposal of a syringe with a needle by placing it into a red sharps disposal container. The image demonstrates safe handling practices for used injection devices.*
FDA Label Image

Pen-parts-before-use (Pen Parts Before Use)

Pen-parts-before-use (Pen Parts Before Use)
An instructional illustration showing a SAPHNELO injection pen before use. The diagram labels the pen's cap, a viewing window displaying the liquid medicine inside, and a label indicating the expiration date.*
FDA Label Image

Pen-parts-after-use (Pen Parts After Use)

Pen-parts-after-use (Pen Parts After Use)
An instructional diagram showing the components of the SAPHNELO injection pen after use. It identifies the removed cap, protective sleeve, green needle guard containing the needle, and the green plunger of the subcutaneous injection device.*
FDA Label Image

Pen-step-1 (Pen Step 1)

Pen-step-1 (Pen Step 1)
An illustrated instructional diagram showing one SAPHNELO pen from the refrigerator and related injection supplies. It also depicts an alcohol wipe, cotton ball or gauze, small bandage, and sharps disposal container, labeled as not included with the pen.*
FDA Label Image

Pen-60-minute-clock (Pen 60 Minute Clock)

Pen-60-minute-clock (Pen 60 Minute Clock)
An illustration of a stopwatch showing '60 min' in the center, indicating a 60-minute time interval.*
FDA Label Image

Pen-step-3 (Pen Step 3)

Pen-step-3 (Pen Step 3)
An instructional illustration showing a hand holding a SAPHNELO injection pen. The image highlights inspecting the dose window and checking the lot number and expiration date on the device before use. This depicts proper handling and visual inspection prior to subcutaneous administration.*
FDA Label Image

Pen-step-4 (Pen Step 4)

Pen-step-4 (Pen Step 4)
Illustration depicting injection sites for SAPHNELO (anifrolumab-fnia) subcutaneous injection. Areas marked with a mesh pattern indicate sites for injections administered by a caregiver only, located on the upper outer arms. Solid black areas indicate injection sites suitable for self-injection or caregiver administration, including the abdomen and front thighs.*
FDA Label Image

Pen-step-5-washing-hands (Pen Step 5 Washing Hands)

Pen-step-5-washing-hands (Pen Step 5 Washing Hands)
Illustration showing handwashing with running water to demonstrate proper hygiene practice. The image depicts water flowing from a faucet over two hands, indicating scrubbing and rinsing.*
FDA Label Image

Pen-step-5-alcohol-wipe (Pen Step 5 Alcohol Wipe)

Pen-step-5-alcohol-wipe (Pen Step 5 Alcohol Wipe)
An instructional line drawing showing a hand holding a cloth or wipe, depicted as cleaning or pressing on a surface. The image is simple with minimal detail, focusing on the hand and cloth interaction.*
FDA Label Image

Step_6_pen (Step 6 Pen)

Step_6_pen (Step 6 Pen)
An instructional illustration showing two hands holding parts of a SAPHNELO injection device. The left hand holds a cap being pulled off, with labels identifying the 'Cap' and 'Protective Sleeve.' The right hand holds the injection device with the 'Green needle guard' visible at the tip.*
FDA Label Image

Pen-step-7-a (Pen Step 7 A)

Pen-step-7-a (Pen Step 7 A)
Illustration showing a hand holding a subcutaneous injection device at a 90-degree angle to the skin surface, demonstrating the proper injection technique for SAPHNELO (Anifrolumab-fnia) injection solution.*
FDA Label Image

Pen-step-7-b (Pen Step 7 B)

Pen-step-7-b (Pen Step 7 B)
An instructional illustration showing a hand holding a SAPHNELO injection device vertically with the bottom tip positioned against the skin, accompanied by a downward arrow indicating the injection direction for subcutaneous administration.*
FDA Label Image

Pen-step-7-c (Pen Step 7 C)

Pen-step-7-c (Pen Step 7 C)
Instructional illustration showing a hand holding a SAPHNELO injection device vertically with the tip pressed down, accompanied by a timer icon indicating 15 seconds. This likely demonstrates the proper administration time for the subcutaneous injection solution of anifrolumab-fnia.*
FDA Label Image

Pen-step-7-d (Pen Step 7 D)

Pen-step-7-d (Pen Step 7 D)
Instructional illustration showing the step of administering an injection using a prefilled syringe device, held vertically with the needle tip pointed downward toward the skin. The user's hand grips the device, and an arrow indicates upward movement of a part of the device or the plunger during injection preparation or administration.*
FDA Label Image

Pen-step-8-viewing-window (Pen Step 8 Viewing Window)

Pen-step-8-viewing-window (Pen Step 8 Viewing Window)
Illustration of a hand holding a subcutaneous injection pen device. The device shows a small window with a green indicator, likely representing medication or dose status. This image relates to the administration of SAPHNELO (Anifrolumab-fnia) injection solution for subcutaneous use.*
FDA Label Image

Pen-step-8-before-after-injection (Pen Step 8 Before After Injection)

Pen-step-8-before-after-injection (Pen Step 8 Before After Injection)
An instructional diagram showing the visual appearance of a SAPHNELO injection device before and after use. The illustration compares the device state immediately prior to injection and the device state after the injection is completed.*
FDA Label Image

Pen-step-9 (Pen Step 9)

Pen-step-9 (Pen Step 9)
An instructional illustration showing a hand pinching or preparing a piece of material, likely as part of a subcutaneous injection procedure or related preparation step.*
FDA Label Image

Pen-step-10 (Pen Step 10 01)

Pen-step-10 (Pen Step 10 01)
An instructional illustration showing a hand holding a prefilled injection pen, positioned above a sharps disposal container, demonstrating safe disposal of the injection device after use.*
FDA Label Image

Carton_1_sub_cut_inj_120mg_zero_point_8ml (Carton 1 Sub Cut Inj 120mg Zero Point 8ml)

Carton_1_sub_cut_inj_120mg_zero_point_8ml (Carton 1 Sub Cut Inj 120mg Zero Point 8ml)
Label for Saphnelo (anifrolumab-fnia) Injection, 120 mg/0.8 mL, a subcutaneous injection solution. The label includes a visual of a pre-filled syringe and instructions stating it is for subcutaneous use only, not to shake, freeze, or expose to heat. Manufactured and distributed by AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Multipack_pdp (Multipack Pdp)

Multipack_pdp (Multipack Pdp)
SAPHNELO Pen 120 mg/0.8 mL (anifrolumab-fnia) injection for subcutaneous use. The label indicates this product is dispensed in a sealed carton containing 4 single-dose autoinjectors. It is manufactured by AstraZeneca Pharmaceuticals LP and includes instructions for weekly use and storage precautions to avoid light, shaking, freezing, and heat exposure.*
FDA Label Image

Iv_pdp (Iv Pdp)

Iv_pdp (Iv Pdp)
SAPHNELO (anifrolumab-fnia) Injection 300 mg/2 mL (150 mg/mL) label for subcutaneous administration. The label specifies intravenous infusion after dilution, includes storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F), and cautions to keep the vial in its original carton and not to shake or freeze. The packaging indicates a single-dose vial and is labeled by AstraZeneca Pharmaceuticals LP.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.